LQDA - Liquidia Technologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LQDA is currently covered by 5 analysts with an average price target of $29.32. This is a potential upside of $10.11 (52.63%) from yesterday's end of day stock price of $19.21.

Liquidia Technologies's activity chart (see below) currently has 40 price targets and 71 ratings on display. The stock rating distribution of LQDA is 92.68% BUY, 2.44% SELL and 4.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.55% with an average time for these price targets to be met of 353.43 days.

Highest price target for LQDA is $37, Lowest price target is $13, average price target is $28.4.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 02-Jun-2025. First documented stock forecast 20-Aug-2018.

Currently out of the existing stock ratings of LQDA, 38 are a BUY (92.68%), 1 are a SELL (2.44%), 2 are a HOLD (4.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$32

$12.79 (66.58%)

$25

2 months 7 days ago
(02-Jun-2025)

14/31 (45.16%)

$15.13 (89.69%)

523

Buy

$35

$15.79 (82.20%)

$29

2 months 12 days ago
(28-May-2025)

5/12 (41.67%)

$20.82 (146.83%)

415

Buy

$37

$17.79 (92.61%)

$36

2 months 12 days ago
(28-May-2025)

4/9 (44.44%)

$22.82 (160.93%)

417

Hold

$13

$-6.21 (-32.33%)

2 months 21 days ago
(19-May-2025)

1/5 (20%)

$-4.03 (-23.66%)

38

Buy

$25

$5.79 (30.14%)

$29

11 months 21 days ago
(19-Aug-2024)

3/5 (60%)

$15.21 (155.36%)

775

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LQDA (Liquidia Technologies) average time for price targets to be met?

On average it took 353.43 days on average for the stock forecasts to be realized with a an average price target met ratio 48.55

Which analyst has the current highest performing score on LQDA (Liquidia Technologies) with a proven track record?

JULIAN HARRISON

Which analyst has the current lower performing score on LQDA (Liquidia Technologies) with a proven track record?

ANDREAS ARGYRIDES

Which analyst has the most public recommendations on LQDA (Liquidia Technologies)?

Julian Harrison works at BTIG and has 5 price targets and 3 ratings on LQDA

Which analyst is the currently most bullish on LQDA (Liquidia Technologies)?

Greg Harrison with highest potential upside - $17.79

Which analyst is the currently most reserved on LQDA (Liquidia Technologies)?

Liana Moussatos with lowest potential downside - -$16.21

Liquidia Technologies in the News

Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates

Vericel Corporation (VCEL) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +75.00%. A quarter ago, it...

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...

Release Date: May 08, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Liquidia Corp (NASDAQ:LQDA) is preparing for the potential launch of its first internally developed commercial product, Erepia, which targets pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?